Bayer funds educational programs to improve clinician understanding of cardio-renal risk and recent advances in chronic kidney disease care for non-diabetic patients.
Funder: Bayer
Due Dates: Rolling (monthly review; allow 45 days for response)
Funding Amounts: No fixed amount specified; detailed budget required with application.
Summary: Supports educational initiatives to improve clinician knowledge of chronic kidney disease in non-diabetic patients, focusing on cardio-renal risk and recent advances.
Key Information: Proposals must comply with ACCME or equivalent standards; monthly review cycle.
This grant opportunity from Bayer supports educational programs aimed at addressing the unmet needs of patients with chronic kidney disease (CKD) who do not have diabetes. The goal is to raise awareness among clinicians—including nephrologists, internal medicine physicians, primary care providers, and cardiologists—about the residual cardio-renal risk in non-diabetic CKD patients. Funded projects should promote understanding of cardiovascular risks, guideline-recommended screening (such as uACR and eGFR), and recent advances in the care of this patient population. The initiative encourages innovative and enduring educational formats, including podcasts, downloadable slides, virtual events, and social media outreach.